We are live on ! Find out more
CP

Covalent Partners Portfolio holdings

AUM $17.6M
1-Year Est. Return 2.91%
This Fund
S&P 500
This Quarter Est. Return
+2.48%
1 Year Est. Return
+2.91%
3 Year Est. Return
+36.56%
5 Year Est. Return
+67.28%
10 Year Est. Return
+115.1%
AUM
$31.3M
AUM Growth
+$3.63M
Cap. Flow
+$4.41M
Cap. Flow %
14.12%
Top 10 Hldgs %
94.55%
Holding
28
New
3
Increased
1
Reduced
2
Closed
3

Sector Composition

Rank Sector Weight
1 Energy 10.46%
2 Communication Services 5.87%
3 Industrials 4.33%
4 Consumer Discretionary 3.13%
5 Healthcare 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIVW
26
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
-100,000
Closed -$248K

Similar funds

Covalent Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Covalent Partners held 28 positions worth $31.3M, up 13% from $27.6M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Covalent Partners deployed $4.41M of net new capital in Q3 2023, opening 3 new positions and adding to 1 existing holding. Its largest new stake was Cinemark Holdings: 100,000 shares worth $1.83M.

By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 9.5% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was Delta Air Lines, an estimated $1.5M trimmed.

  • Covalent Partners's largest Q3 2023 buy was Cinemark Holdings: 100,000 shares worth $1.83M.
  • Covalent Partners added most to iShares 7-10 Year Treasury Bond ETF in Q3 2023, an estimated $239K increase.
  • Covalent Partners's biggest Q3 2023 reduction was Delta Air Lines, cutting an estimated $1.5M.
  • Covalent Partners fully exited Southwest Airlines in Q3 2023, selling an estimated $2.53M.
  • Covalent Partners's ten largest holdings make up 95% of its $31.3M portfolio in Q3 2023.
  • Covalent Partners opened 3 new positions and closed 3 in Q3 2023.
  • Covalent Partners's portfolio value rose 13% quarter-over-quarter to $31.3M.

Based on Covalent Partners's 13F filing for Q3 2023, filed 14 Nov 2023.